N-AD: Orally Administered Nicotinamide Riboside Over Two Years as a Potential Disease Modifying Treatment for Alzheimer's Disease
Clinical trial NCT07741071 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07741071
- Sponsor
- Haukeland University Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-15
- Primary completion
- 2030-04-30
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.